UNH trades about 5% below the average analyst target of $459.12 while staying above its 50‑day moving average, and the raised 2026 outlook leaves upside toward the $529 high despite the CFO’s caution.

Investor sentiment remains upbeat as the market lauds the raised outlook and views UNH as cheap, though the CFO’s warning sparked a brief pullback. Overall momentum stays positive.

Long‑term risk centers on the DOJ antitrust probe and Medicare Advantage execution; the CFO’s warning underscores potential margin pressure, keeping the outlook neutral for now.

The daily RSI at 38 indicates slight oversold conditions and a bullish MACD crossover signals a near‑term rally toward the $460 target zone.